SCHEMBL4331396

SCHEMBL4331396

[CH]1CCCC2CCC1C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4219851 0.90
SCHEMBL4325388 0.90
SCHEMBL4317463 0.83
SCHEMBL575142 0.83
SCHEMBL1848185 0.79
SCHEMBL4315016 0.79
SCHEMBL847372 0.69
SCHEMBL3987202 0.69
SCHEMBL22325343 0.69
SCHEMBL22325310 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7557117-B2 4-oxoimidazolidine-2-spiropiperidine derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2009-07-07 US disclosed
EP-1420020-B1 4-OXOIMIDAZOLIDINE-2-SPIROPIPERIDINE DERIVATIVE BANYU PHARMA CO LTD (JP) 2008-05-28 EP disclosed
US-20070078153-A1 4-Oxoimidazolidine-2-spiropiperidine derivatives MSD K.K. (JP) 2007-04-05 US disclosed
US-7192964-B2 4-oxoimidazolidine-2-spiropiperidine derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-03-20 US disclosed
US-6969712-B2 Benzimidazole derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2005-11-29 US disclosed
US-20050004363-A1 4-oxoimidazolidine-2-spiropiperidine derivatives MSD K.K. (JP) 2005-01-06 US disclosed
EP-1420020-A1 4-OXOIMIDAZOLIDINE-2-SPIROPIPERIDINE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2004-05-19 EP disclosed
US-20040044056-A1 Benzimidazole derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2004-03-04 US disclosed
EP-1342717-A1 BENZIMIDAZOLE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2003-09-10 EP disclosed